UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000005260
Receipt number R000006257
Scientific Title Efficacy of myocardial protection by nicorandil during open-heart surgery under cardiopulmonary bypass
Date of disclosure of the study information 2011/04/01
Last modified on 2018/09/20 14:24:51

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of myocardial protection by nicorandil during open-heart surgery under cardiopulmonary bypass

Acronym

Myocardial protection by nicorandil

Scientific Title

Efficacy of myocardial protection by nicorandil during open-heart surgery under cardiopulmonary bypass

Scientific Title:Acronym

Myocardial protection by nicorandil

Region

Japan


Condition

Condition

valvular heart disease

Classification by specialty

Anesthesiology Cardiovascular surgery Operative medicine
Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

efficacy of myocardial protection by nicorandil during open-heart surgery under cardiopulmonary bypass

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Not applicable


Assessment

Primary outcomes

Hemodynamics, markers for myocardial damage(CK-MB,TnT,H-FABP etc) at five time points(anesthesia induction, just, 1hr, 5hr and 24hr after cardiopulmonary bypass stopped).

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -but assessor(s) are blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

4

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

aortic valve surgery
transvenous administration of nicorandil (6mg/hr) for 24 hours.

Interventions/Control_2

aortic valve surgery
control

Interventions/Control_3

cardiac valve surgery(except aortic valve), transvenous administration of nicorandil (6mg/hr) for 24 hours.

Interventions/Control_4

cardiac valve surgery(except aortic valve)
control

Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

elective heart valve replacement or plasty surgery

Key exclusion criteria

emergency surgery

Target sample size

60


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Sachiko Jomura

Organization

Kansai Medical University Hirakata hospital

Division name

Dept. Anesthesiology

Zip code


Address

2-3-1 Shin-machi Hirakata-city Osaka

TEL


Email



Public contact

Name of contact person

1st name
Middle name
Last name Sachiko Jomura

Organization

Kansai Medical University Hirakata hospital

Division name

Dept. Anesthesiology

Zip code


Address

2-3-1 Shin-machi Hirakata-city Osaka

TEL


Homepage URL


Email



Sponsor or person

Institute

Kansai Medical University, Dept. Anesthesiology

Institute

Department

Personal name



Funding Source

Organization

Kansai Medical University, Dept. Anesthesiology

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2011 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2011 Year 03 Month 31 Day

Date of IRB


Anticipated trial start date

2011 Year 04 Month 01 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2011 Year 03 Month 16 Day

Last modified on

2018 Year 09 Month 20 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000006257


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name